UPC APP 37868/2024
EP2196231 · System for ambulatory drug infusion comprising a filling apparatus for flexible containers
- Case details
- Status—ActionProcedural applicationCategoryOther procedural
- Parties
- Claimants
- Tandem Diabetes Care, Inc.Operating co.
- Tandem Diabetes Care Europe B.V.Operating co.
Representatives- Charlotte Garnitsch-Taylor Wessing
- Wim Maas-Taylor Wessing
- Alexander Rubusch-Taylor Wessing
Respondents- Roche Diabetes Care GmbHOperating co.
Representatives- Christof Augenstein-Kather Augenstein
- Katharina Brandt-Kather Augenstein
- Robert Knaps-Kather Augenstein
- Thomas Kronbergersupporting-Grünecker Patent- und Rechtsanwälte PartGmbH
- Division
- Paris CD
- Judges
- Technology
- InstrumentsMedical technology
- Language
- —
- First decided
- Jun 27, 2024
| Median days to first decision | |
|---|---|
| All UPC | 124 |
| Paris CD | Locked |
| Judge Paolo Catallozzi | Locked |
At the UPC: Tandem Diabetes Care Group (18 cases)·Roche Group (29 cases)
This dispute contains 9 other proceedings
UPC CoA 120/2025·UPC CFI 11/2025·UPC CFI 88/2024·UPC CFI 454/2023·UPC CFI 455/2023 and 4 more
1 other defendants litigating the same or a related patent
- 2024-06-27
Summary: Order of the Paris Central Division (judge-rapporteur Catallozzi) granting Roche Diabetes Care GmbH's application for extension of the deadline for filing its rejoinder to the reply to the defence in a revocation action for EP 2 196 231. Roche argued that Tandem Diabetes Care submitted new prior art in their reply that had not previously been discussed, and that it needed additional time to address both the new prior art and a parallel counterclaim for revocation before the Hamburg Local Division. The court extended the deadline to 29 July 2024, exercising its discretionary power under principles of proportionality, flexibility, fairness and equity.
Show the legal issues (3)
- Extension of time for rejoinder where new prior art introduced
- Interaction between central revocation and counterclaim for revocation
- Discretionary time extension under proportionality and fairness principles
- B19C33155E604F7E880EE188C460324E_en.pdf2024-06-27EN